Proteomic profiling study of primary PCa revealed that high pro-NPY expression, regardless of the ERG status, was associated with an increased PCa-specific risk of death, especially in patients with Gleason score ≤ 7 tumours. The gene discussed is NPY; the disease is neoplasm.